Explore
Validate
LearnHPA002636
antibody from Atlas Antibodies
Targeting: AURKA
AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA002636 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA002636, RRID:AB_1845217
- Product name
- Anti-AURKA
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AURKA, Gene description: aurora kinase A, Alternative Gene Names: AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7, Validated applications: ICC, IHC, WB, Uniprot ID: O14965, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions
Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis
Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma
Lavogina D, Krõlov M, Vellama H, Modhukur V, Di Nisio V, Lust H, Eskla K, Salumets A, Jaal J
Scientific Reports 2024;14(1)
Scientific Reports 2024;14(1)
Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
Skov N, Alves C, Ehmsen S, Ditzel H
International Journal of Molecular Sciences 2022;23(17):10053
International Journal of Molecular Sciences 2022;23(17):10053
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
Løkkegaard S, Elias D, Alves CL, Bennetzen MV, Lænkholm AV, Bak M, Gjerstorff MF, Johansen LE, Vever H, Bjerre C, Kirkegaard T, Nordenskjöld B, Fornander T, Stål O, Lindström LS, Esserman LJ, Lykkesfeldt AE, Andersen JS, Leth-Larsen R, Ditzel HJ
NPJ breast cancer 2021 Jan 4;7(1):2
NPJ breast cancer 2021 Jan 4;7(1):2
Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
Ma X, Zhou L, Zheng S
PeerJ 2020;8
PeerJ 2020;8
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
Shah K, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang V, Hemmati G, Martins M, Maynard A, Kuhn J, Galeas J, Donnella H, Kaushik S, Ku A, Dumont S, Krings G, Haringsma H, Robillard L, Simmons A, Harding T, McCormick F, Goga A, Blakely C, Bivona T, Bandyopadhyay S
Nature Medicine 2018;25(1):111-118
Nature Medicine 2018;25(1):111-118
Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis
Zhan S, Liu B, Linghu H
Oncology Reports 2018
Oncology Reports 2018
Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma
Koh H, Jang B, Hyun C, Kim Y, Hyun J, Chang W, Maeng Y
Journal of Pathology and Translational Medicine 2017;51(1):32-39
Journal of Pathology and Translational Medicine 2017;51(1):32-39
No comments: Submit comment
No validations: Submit validation data